Indivior PLC Ordinary Share INDV
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
ROSEN, A LONGSTANDING LAW FIRM, Encourages Indivior PLC Investors to Secure Counsel Before Important October 1 Deadline in Securities Class Action – INDV
-
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Indivior PLC (INDV)
-
Indivior PLC Sued for Securities Law Violations - Contact The Gross Law Firm Before October 1, 2024 to Discuss Your Rights - INDV
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, CrowdStrike, DXC, and Five Below and Encourages Investors to Contact the Firm
-
DEADLINE ALERT for ABR, FIVE, INDV, DXC: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
-
Levi & Korsinsky Notifies Indivior PLC Investors of a Class Action Lawsuit and Upcoming Deadline – INDV
-
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Indivior PLC of Class Action Lawsuit and Upcoming Deadlines - INDV
-
INDV Investors Have Opportunity to Lead Indivior PLC Securities Fraud Lawsuit with the Schall Law Firm
Trading Information
- Previous Close Price
- $9.46
- Day Range
- $9.51–9.93
- 52-Week Range
- $9.05–23.22
- Bid/Ask
- $9.59 / $10.21
- Market Cap
- $1.29 Bil
- Volume/Avg
- 466,954 / 825,556
Key Statistics
- Price/Earnings (Normalized)
- 3.54
- Price/Sales
- 1.15
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 7.35%
Company Profile
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,164
- Website
- https://www.indivior.com
Comparables
Valuation
|
Metric
|
INDV
|
AZN
|
KNSA
|
|---|---|---|---|
Price/Earnings (Normalized) | 3.54 | 20.17 | 218.98 |
Price/Book Value | — | 5.74 | 3.94 |
Price/Sales | 1.15 | 4.63 | 5.09 |
Price/Cash Flow | — | 21.45 | 69.76 |
Price/Earnings
INDV
AZN
KNSA
Financial Strength
|
Metric
|
INDV
|
AZN
|
KNSA
|
|---|---|---|---|
Quick Ratio | 0.65 | 0.69 | 2.84 |
Current Ratio | 0.85 | 0.89 | 3.57 |
Interest Coverage | −5.25 | 5.45 | — |
Quick Ratio
INDV
AZN
KNSA
Profitability
|
Metric
|
INDV
|
AZN
|
KNSA
|
|---|---|---|---|
Return on Assets (Normalized) | 12.96% | 57.63% | 2.27% |
Return on Equity (Normalized) | — | 151.23% | 2.73% |
Return on Invested Capital (Normalized) | 80.49% | 84.88% | 2.66% |
Return on Assets
INDV
AZN
KNSA
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Ttngsprb | Ngvs | $86.8 Bil | |||
| Merck KGaA ADR
MKKGY
| Fxcqstzgy | Jjwpkxq | $75.4 Bil | |||
| Haleon PLC ADR
HLN
| Tpqfxsk | Tbyl | $48.1 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Rbltxsmw | Mhvll | $20.0 Bil | |||
| Viatris Inc
VTRS
| Nfyktjc | Mdyq | $13.5 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Nqjcktqs | Pjk | $13.3 Bil | |||
| Catalent Inc
CTLT
| Zjrhwfsb | Hlbttt | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Rykntblgz | Bzsjcf | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Lmbjncck | Jxtw | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Dxsblzgmhy | Bzgkt | $2.5 Bil |
United States